⌘K

Equillium, Inc. (EQ)

$0.85 -2.29% $-0.02 Healthcare

Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase Ib clinical trial for the treatment of asthma disease; and Phase Ib clinical trial for the treatment of and lupus nephritis. It also develops EQ101 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ102 to treat various gastrointestinal diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.

Market cap

$30.11M

CEO

Mr. Bruce D. Steel C.F.A.

Full time employees

45.00

Headquarters

La Jolla, CA

IPO Date

Oct 12, 2018

Price-to-earnings (PE) Ratio

-3.70

Earnings-per-share (EPS)

$-0.23

Cash ratio (TTM)

0.55

Current ratio (TTM)

2.08

Net profit margin (TTM)

-19.52%

PE ratio (TTM)

-3.69

PEG ratio (TTM)

-0.15

Price-to-book ratio (TTM)

1.37

Price-to-sales ratio (TTM)

0.72

Quick ratio (TTM)

2.08

Return on assets (TTM)

-19.41%

Return on equity (TTM)

-36.88%

Similar stocks (19)

Edgewise Therapeutics, Inc.

EWTX

$28.67 -2.81% $-0.83

Uptrend

Jasper Therapeutics, Inc.

JSPR

$23.38 -2.23% $-0.53

Uptrend

Trevi Therapeutics, Inc.

TRVI

$3.46 -1.14% $-0.04

Uptrend

HOOKIPA Pharma Inc.

HOOK

$4.61 -2.31% $-0.11

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.04 -8.37% $-0.10

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.25 -6.29% $-0.15

Downtrend

BioAtla, Inc.

BCAB

$1.72 -1.15% $-0.02

Downtrend

Ikena Oncology, Inc.

IKNA

$1.72 0.59% $0.01

Neutral

Spero Therapeutics, Inc.

SPRO

$1.33 -1.85% $-0.02

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.05 -7.24% $-0.16

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 -2.78% $-0.03

Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.95 7.71% $0.21

Downtrend

Cue Biopharma, Inc.

CUE

$0.53 -5.40% $-0.03

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.62 -1.46% $-0.00

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 0.00% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.41 -1.97% $-0.09

Neutral

Cadrenal Therapeutics, Inc.

CVKD

$11.10 -1.11% $-0.12

Neutral

Pasithea Therapeutics Corp.

KTTA

$4.63 -3.61% $-0.17

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.24% $-0.01

Downtrend

ETF Exposure (8)

iShares Micro-Cap ETF

IWC

0.00385%

$125.12 -1.12% $-1.42

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.58 -0.17% $-0.47

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.94 -0.54% $-0.98

Uptrend

Downtrend

Similar stocks (19)

Edgewise Therapeutics, Inc.

EWTX

$28.67 -2.81% $-0.83

Uptrend

Jasper Therapeutics, Inc.

JSPR

$23.38 -2.23% $-0.53

Uptrend

Trevi Therapeutics, Inc.

TRVI

$3.46 -1.14% $-0.04

Uptrend

HOOKIPA Pharma Inc.

HOOK

$4.61 -2.31% $-0.11

Downtrend

Coherus BioSciences, Inc.

CHRS

$1.04 -8.37% $-0.10

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.25 -6.29% $-0.15

Downtrend

BioAtla, Inc.

BCAB

$1.72 -1.15% $-0.02

Downtrend

Ikena Oncology, Inc.

IKNA

$1.72 0.59% $0.01

Neutral

Spero Therapeutics, Inc.

SPRO

$1.33 -1.85% $-0.02

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.05 -7.24% $-0.16

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.05 -2.78% $-0.03

Downtrend

SAB Biotherapeutics, Inc.

SABS

$2.95 7.71% $0.21

Downtrend

Cue Biopharma, Inc.

CUE

$0.53 -5.40% $-0.03

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.62 -1.46% $-0.00

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 0.00% $0.00

Downtrend

Monopar Therapeutics Inc.

MNPR

$4.41 -1.97% $-0.09

Neutral

Cadrenal Therapeutics, Inc.

CVKD

$11.10 -1.11% $-0.12

Neutral

Pasithea Therapeutics Corp.

KTTA

$4.63 -3.61% $-0.17

Downtrend

Quoin Pharmaceuticals, Ltd.

QNRX

$0.56 -2.24% $-0.01

Downtrend

ETF Exposure (8)

iShares Micro-Cap ETF

IWC

0.00385%

$125.12 -1.12% $-1.42

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$97.80 1.74% $1.67

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$97.78 1.74% $1.67

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$137.33 1.73% $2.34

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$281.58 -0.17% $-0.47

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$137.30 1.73% $2.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$181.94 -0.54% $-0.98

Uptrend